Hammond-Weinberger DR , Wang Y , Glavis-Bloom A , Spitzer NC .

	Fig. 1. Glutamate signaling through ionotropic receptors is necessary and sufficient to induce glutamate sensitivity of cultured myocytes. (A) Glutamate-induced Fluo-4 AM fluorescence intensity in acetylcholine-sensitive myocytes (arrowheads) in response to neurotransmitter superfusion of a neuron-myocyte coculture. (B) Digitized fluorescence of six myocytes in response to 5-s superfusion with 5 mM glutamate + 3 µM pancuronium or 1 µM acetylcholine following 18–24 h exposure to 1 µM glutamate in 2 mM Ca2+ culture medium. Traces are offset for clarity. (C) The incidence of glutamate sensitivity of myocytes in neuron-myocyte culture depends on the culture medium. Basal sensitivity in neuron-myocyte cultures in 2 mM Ca2+ increased in the absence of Ca2+ that increases the incidence of glutamatergic neurons but did not decrease significantly in the presence of 1 µM veratridine that decreases the incidence of glutamatergic neurons, ANOVA with Tukey’s range test [F(2, 25) = 7.947]. Myocytes grown in the absence of neurons are unaffected by culture condition. (D) The combination of 50 µM AP5 and 15 µM NBQX, but not either inhibitor alone, decreased incidence of glutamate responses in myocyte-only cultures grown in the presence of 1 µM glutamate. ANOVA [F(4, 100) = 13.37, P < 0.0001] with Dunnett’s post hoc test. (C and D) n ≥ 8 cultures per group with 8–10 myocytes per culture. Values are mean ± SEM, **P < 0.01, ***P < 0.001, ****P < 0.0001. See also SI Appendix, Figs. S1 and S2.
	Fig. 2. Metabotropic glutamate receptors do not stimulate glutamate-induced sensitivity of myocytes. Antagonists (Ant) to type I mGluRs (100 µM AIDA) but not type II mGluRs (100 µM LY341495) or type III mGluRs (100 µM MSOP) enhanced the incidence of glutamate sensitivity in the absence of exogenous glutamate (ANOVA with Dunnett’s post hoc test compared to control F(6, 80) = 2.207; a, P < 0.05), with no additional gain in sensitivity in the presence of glutamate (ANOVA F(6, 103) = 5.091; P < 0.05). The increased incidence of glutamate sensitivity in response to glutamate was blocked in myocytes cultured in the presence of agonists (Ago) for each class of mGluR (I, 100 µM CHPG; II, 100 µM LY354740; III, 20 µM L-AP4) (two-tailed unpaired t tests between glu+ and glu- pairs). n ≥ 8 cultures per group with 8–10 myocytes per culture. Values are mean ± SEM. **P < 0.01, ****P < 0.0001.
	Fig. 3. Glutamate signaling to ionotropic receptors is necessary and sufficient to induce NMDA receptor up-regulation in myocytes in vivo. (A) Agarose beads loaded with drugs were implanted at stage 21 (22.5 h) and animals raised to stage 40 (2.8 d). (B) Glutamate delivered by agarose beads stimulated an increase in GluN1 immunoreactivity (% of labeled area within indicated borders) in trunk myocytes. (C) Bead delivery of 10 μM AMPA and 10 μM NMDA also induced expression of GluN1 in myocytes, ANOVA [F(2, 51) = 26.8] with Dunnett’s post hoc test. (D) Bead delivery of 0.5 mM AP5 plus 0.15 mM NBQX abrogated the glutamate-induced increase in GluN1 expression, ANOVA [F(3, 86) = 31.47]. n = 4 independent experiments for each graph. The lower right number on each bar is the number of embryos examined. Values are mean ± SEM. ****P < 0.0001. See also SI Appendix, Fig. S3.
	Fig. 4. Inhibitors of adenylate cyclase and MAP kinases suppress glutamate-induced glutamate sensitivity of myocytes. Coincubation of glutamate with pharmacological inhibitors identified adenylate cyclase (AC; 5 μM SQ22536), MEK1/2 (10 μM U0126), JNK (5 μM SP600125), and p38 (10 μM SB203580) as mediators of the increase in glutamate sensitivity, ANOVA [F(9, 131) = 5.265] with Tukey’s post hoc test. n ≥ 8 cultures per group and 8–10 myocytes per culture. Values are mean ± SEM. ****P < 0.0001.
	Fig. 5. p38 is required for glutamate-induced glutamate sensitivity of myocytes and up-regulation of NMDA receptors. (A) MO-mediated knockdown of p38β or p38γ in vitro abolished the glutamate-mediated increased sensitivity of myocytes to glutamate without affecting baseline sensitivity, unpaired t tests between −glu and +glu pairs. n ≥ 5 cultures per group with 8–10 myocytes per culture. (B) Western blots of cultured myocytes exposed to glutamate were probed for p-p38, p38, and actin. (C) The ratio of phosphorylated versus total p38 increased briefly after glutamate exposure. Values are from three experimental replicates, one-sample t tests to expected mean of 1 (control). (D) MO-mediated p38β knockdown in vivo eliminated the glutamate-induced increase in GluN1 expression, ANOVA [F(3, 77) = 18.98] with Tukey’s post hoc test. (E) Quantification of D. n = 4 independent experiments for each bar. Values are mean ± SEM. *P < 0.05, ****P < 0.0001.
	Fig. 6. JNK is required for glutamate-induced myocyte glutamate sensitivity and NMDA receptor up-regulation. (A) MO-mediated knockdown of JNK1 in vitro abolished the glutamate-mediated increased sensitivity of myocytes to glutamate (ANOVA F(3, 35) = 6.87 with Tukey’s post hoc test). n ≥ 8 cultures per group with 8–10 myocytes per culture. (B) Western blots of cultured myocytes exposed to glutamate were probed for p-JNK, JNK, and actin. (C) The ratio of phosphorylated to total JNK decreased temporarily after glutamate exposure. Values are from three experimental replicates; one-sample t tests to expected mean of 1 (control). (D) MO-mediated JNK knockdown in vivo eliminated the effect of glutamate on increased GluN1 expression, ANOVA [F(3, 81) = 43.74] with Tukey’s post hoc test. (E) Quantification of D. n = 4 independent experiments. Values are mean ± SEM. *P < 0.05, ***P < 0.001, ****P < 0.0001.
	Fig. 7. MEF2 is required for NMDA receptor subunit up-regulation in vivo. (A) GluN1 up-regulation is abolished by MEF2C MO-mediated knockdown. (B) Quantification of A, n = 4 independent experiments. Values are mean ± SEM, ANOVA [F(3, 75) = 21.67] with Tukey’s post hoc test. ****P < 0.0001.
	Fig. 8. Model of neurotransmitter-receptor matching. Glutamate activation of ionotropic receptors (iGluR) deactivates JNK through an unknown intermediary to regulate jun/ATF transcription factors that bind to the AP-1 site in the GluN1 promoter. In parallel, iGluR stimulation leads to activation of adenylate cyclase (AC) to generate cAMP that activates p38 in combination with metabotropic actions of NMDARs. Ca2+ binding Ca2+-mediated activation of PI3K, and p38-mediated phosphorylation of MEF2 dimers facilitate DNA binding and transactivation. MEF2 requires SP1/3 for efficient DNA binding to the GluN1 promoter. The combined actions of these pathways create a feedforward cycle that allows sustained exposure to glutamate to up-regulate and maintain NMDA receptor subunit GluN1 expression.

Ahn, Alterations in GluR2 AMPA receptor phosphorylation at serine 880 following group I metabotropic glutamate receptor stimulation in the rat dorsal striatum. 2010, Pubmed

Ahn, Alterations in GluR2 AMPA receptor phosphorylation at serine 880 following group I metabotropic glutamate receptor stimulation in the rat dorsal striatum. 2010, Pubmed
Bai, Cloning and analysis of the 5' flanking sequence of the rat N-methyl-D-aspartate receptor 1 (NMDAR1) gene. 1993, Pubmed
Bertuzzi, Adult spinal motoneurons change their neurotransmitter phenotype to control locomotion. 2018, Pubmed
Bestman, Morpholino studies in Xenopus brain development. 2014, Pubmed , Xenbase
Borges, Dual role for calcium in agrin signaling and acetylcholine receptor clustering. 2002, Pubmed
Borodinsky, Activity-dependent homeostatic specification of transmitter expression in embryonic neurons. 2004, Pubmed , Xenbase
Borodinsky, Activity-dependent neurotransmitter-receptor matching at the neuromuscular junction. 2007, Pubmed , Xenbase
Brunelli, Glutamatergic reinnervation through peripheral nerve graft dictates assembly of glutamatergic synapses at rat skeletal muscle. 2005, Pubmed
Chen, Cyclic AMP activates p38 mitogen-activated protein kinase in Th2 cells: phosphorylation of GATA-3 and stimulation of Th2 cytokine gene expression. 2000, Pubmed
Cheng, SNARE proteins are essential in the potentiation of NMDA receptors by group II metabotropic glutamate receptors. 2013, Pubmed
Clements, The time course of glutamate in the synaptic cleft. 1992, Pubmed
Demarque, Activity-dependent expression of Lmx1b regulates specification of serotonergic neurons modulating swimming behavior. 2010, Pubmed , Xenbase
Dulcis, Illumination controls differentiation of dopamine neurons regulating behaviour. 2008, Pubmed , Xenbase
Dulcis, Neurotransmitter Switching Regulated by miRNAs Controls Changes in Social Preference. 2017, Pubmed , Xenbase
Dulcis, Neurotransmitter switching in the adult brain regulates behavior. 2013, Pubmed
Farhy-Tselnicker, Astrocyte-Secreted Glypican 4 Regulates Release of Neuronal Pentraxin 1 from Axons to Induce Functional Synapse Formation. 2017, Pubmed
Ferrari, Spontaneous calcium transients regulate myofibrillogenesis in embryonic Xenopus myocytes. 1996, Pubmed , Xenbase
Flavell, Activity-dependent regulation of MEF2 transcription factors suppresses excitatory synapse number. 2006, Pubmed
Francolini, Glutamatergic reinnervation and assembly of glutamatergic synapses in adult rat skeletal muscle occurs at cholinergic endplates. 2009, Pubmed
Gu, Spontaneous neuronal calcium spikes and waves during early differentiation. 1994, Pubmed , Xenbase
Guo, Comparative analysis reveals distinct and overlapping functions of Mef2c and Mef2d during cardiogenesis in Xenopus laevis. 2014, Pubmed , Xenbase
Han, Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation. 1997, Pubmed
Heasman, Morpholino oligos: making sense of antisense? 2002, Pubmed , Xenbase
Huebsch, Rapsyn-mediated clustering of acetylcholine receptor subunits requires the major cytoplasmic loop of the receptor subunits. 2003, Pubmed
Korada, Development of GABA, glycine, and their receptors in the auditory brainstem of gerbil: a light and electron microscopic study. 1999, Pubmed
Kotak, A developmental shift from GABAergic to glycinergic transmission in the central auditory system. 1998, Pubmed
Krainc, Synergistic activation of the N-methyl-D-aspartate receptor subunit 1 promoter by myocyte enhancer factor 2C and Sp1. 1998, Pubmed
Lan, Activation of metabotropic glutamate receptor 1 accelerates NMDA receptor trafficking. 2001, Pubmed , Xenbase
Liang, Coupling of agonist-induced AMPA receptor internalization with receptor recycling. 2001, Pubmed
Mangiavacchi, Stimulation of N-methyl-D-aspartate receptors, AMPA receptors or metabotropic glutamate receptors leads to rapid internalization of AMPA receptors in cultured nucleus accumbens neurons. 2004, Pubmed
Mayer, Regulation of NMDA receptor desensitization in mouse hippocampal neurons by glycine. 1989, Pubmed
Misgeld, Roles of neurotransmitter in synapse formation: development of neuromuscular junctions lacking choline acetyltransferase. 2002, Pubmed
Nabavi, Metabotropic NMDA receptor function is required for NMDA receptor-dependent long-term depression. 2013, Pubmed
Nakanishi, Metabotropic glutamate receptors: synaptic transmission, modulation, and plasticity. 1994, Pubmed
Niswender, Metabotropic glutamate receptors: physiology, pharmacology, and disease. 2010, Pubmed
Ohnishi, Nemo-like kinase, an essential effector of anterior formation, functions downstream of p38 mitogen-activated protein kinase. 2010, Pubmed , Xenbase
Patrick, Ubiquitin-mediated proteasome activity is required for agonist-induced endocytosis of GluRs. 2003, Pubmed
Pillai, Lhx1 and Lhx5 maintain the inhibitory-neurotransmitter status of interneurons in the dorsal spinal cord. 2007, Pubmed
Pinard, Glutamatergic modulation of synaptic plasticity at a PNS vertebrate cholinergic synapse. 2003, Pubmed
Robert, How AMPA receptor desensitization depends on receptor occupancy. 2003, Pubmed
Sanes, Development of the neuromuscular junction: genetic analysis in mice. 1998, Pubmed
Spitzer, Implications of activity-dependent neurotransmitter-receptor matching. 2008, Pubmed
Spitzer, Neurotransmitter Switching in the Developing and Adult Brain. 2017, Pubmed
Tadokoro, Involvement of unique leucine-zipper motif of PSD-Zip45 (Homer 1c/vesl-1L) in group 1 metabotropic glutamate receptor clustering. 1999, Pubmed
Tanabe, Specification of motor neuron identity by the MNR2 homeodomain protein. 1998, Pubmed , Xenbase
Thor, The Drosophila islet gene governs axon pathfinding and neurotransmitter identity. 1997, Pubmed
Walder, Immunohistological and electrophysiological evidence that N-acetylaspartylglutamate is a co-transmitter at the vertebrate neuromuscular junction. 2013, Pubmed
Wang, Group II metabotropic glutamate receptor agonist LY379268 regulates AMPA receptor trafficking in prefrontal cortical neurons. 2013, Pubmed
Watson, Synaptic transmission and plasticity require AMPA receptor anchoring via its N-terminal domain. 2017, Pubmed
Yamanaka, JNK functions in the non-canonical Wnt pathway to regulate convergent extension movements in vertebrates. 2002, Pubmed , Xenbase
Zarain-Herzberg, Cloning and characterization of the chick NMDA receptor subunit-1 gene. 2005, Pubmed